# Aligos Therapeutics, Inc.: Form 8-K, filed May 15, 2024

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: 8-K
- Filed: 2024-05-15
- Accepted by EDGAR: May 15, 2024, 17:01 ET
- Period: 2024-05-09
- Accession: 0001193125-24-139476
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312524139476/d793808d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312524139476/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312524139476/d793808d8k.htm

Filed May 15, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-139476. Last ingested by Listed: Nov 14, 2026, 12:59 ET. No prices; not investment advice.
